sábado, 13 de diciembre de 2025

Trump Weighs Reclassifying Pot; Study Cites Scant Benefit In Medical Use

Trump Weighs Reclassifying Pot; Study Cites Scant Benefit In Medical Use Cannabis is currently a Schedule 1 substance, on par with heroin and LSD. Reclassifying it as a Schedule III drug would put it in the same category as mild prescription painkillers. The change would ease barriers to research, The Washington Post reports. https://kffhealthnews.org/morning-breakout/trump-weighs-reclassifying-pot-study-cites-scant-benefit-in-medical-use/

No hay comentarios: